Royal Bank of Canada’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.82M | Buy |
156,253
+154,109
| +7,188% | +$6.73M | ﹤0.01% | 2109 |
|
|
2025
Q1 | $59K | Sell |
2,144
-2,234
| -51% | -$61.5K | ﹤0.01% | 5136 |
|
|
2024
Q4 | $176K | Sell |
4,378
-1,397
| -24% | -$56.2K | ﹤0.01% | 4469 |
|
|
2024
Q3 | $273K | Buy |
5,775
+1,591
| +38% | +$75.2K | ﹤0.01% | 4145 |
|
|
2024
Q2 | $125K | Buy |
4,184
+3,048
| +268% | +$91.1K | ﹤0.01% | 4746 |
|
|
2024
Q1 | $46K | Sell |
1,136
-10,718
| -90% | -$434K | ﹤0.01% | 5135 |
|
|
2023
Q4 | $302K | Buy |
11,854
+7,096
| +149% | +$181K | ﹤0.01% | 4212 |
|
|
2023
Q3 | $66K | Buy |
4,758
+1,985
| +72% | +$27.5K | ﹤0.01% | 5138 |
|
|
2023
Q2 | $64K | Buy |
2,773
+640
| +30% | +$14.8K | ﹤0.01% | 5205 |
|
|
2023
Q1 | $63K | Sell |
2,133
-3,302
| -61% | -$97.5K | ﹤0.01% | 5116 |
|
|
2022
Q4 | $136K | Buy |
5,435
+4,975
| +1,082% | +$124K | ﹤0.01% | 4759 |
|
|
2022
Q3 | $10K | Buy |
460
+247
| +116% | +$5.37K | ﹤0.01% | 5931 |
|
|
2022
Q2 | $4K | Sell |
213
-1,929
| -90% | -$36.2K | ﹤0.01% | 6261 |
|
|
2022
Q1 | $90K | Sell |
2,142
-5,573
| -72% | -$234K | ﹤0.01% | 5252 |
|
|
2021
Q4 | $490K | Buy |
7,715
+4,158
| +117% | +$264K | ﹤0.01% | 3977 |
|
|
2021
Q3 | $209K | Sell |
3,557
-1,540
| -30% | -$90.5K | ﹤0.01% | 4632 |
|
|
2021
Q2 | $247K | Buy |
5,097
+2,815
| +123% | +$136K | ﹤0.01% | 4424 |
|
|
2021
Q1 | $89K | Buy |
2,282
+2,122
| +1,326% | +$82.8K | ﹤0.01% | 5055 |
|
|
2020
Q4 | $10K | Buy |
+160
| New | +$10K | ﹤0.01% | 5819 |
|